Prognostic Stage IV Breast Cancer AJCC v8 Active Not Recruiting Phase 1 Trials for Docetaxel (DB01248)

DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Active Not Recruiting1 IdentifierTitlePurposeDrugs
NCT03218826PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryTreatment